Anna Dahlgren, Linnea Sjöblom, Stephanie E Bonn, Ylva Trolle Lagerros, Essi Hantikainen
Journal: Nutrition journal 2025;24(1):2
PMID: 39754157
Type 2 diabetes is a long-term condition in which the body cannot properly regulate blood sugar levels. Diet plays a central role in managing this condition, helping to control blood sugar, cholesterol, blood pressure, and body weight. However, many people find it difficult to maintain healthy eating habits. With the increasing use of smartphones, app-based health programmes may offer a convenient way to support dietary change. This study aimed to determine whether a 12-week smartphone-based dietary education programme could improve diet quality and cardiometabolic risk markers in people with type 2 diabetes.
The results showed no significant effect of app use on overall diet quality compared with the control group. However, analyses of food frequency questionnaire data indicated that those following an app-based health programme reduced their intake of saturated fat and unsaturated fat more than the control group. In addition, the app-based health group showed a favourable change in serum triglycerides. No statistically significant differences were found in other dietary variables or cardiometabolic risk markers over the 12 weeks.
In conclusion, while the study found no effect on overall diet quality, it suggests that a smartphone-based dietary education might impact dietary fat intake and corresponding cardiometabolic risk markers (such as triglycerides) in people with type 2 diabetes. Longer-term studies are warranted to further confirm these results. Healthcare professionals could consider mHealth tools as a potential complementary strategy, but expectations should align with the modest and selective effects observed.
BACKGROUND
mHealth, i.e. mobile-health, strategies may be used as a complement to regular care to support healthy dietary habits in primary care patients. We evaluated the effect of a 12-week smartphone-based dietary education on overall diet quality (primary outcome), and dietary intake and cardiometabolic risk markers (secondary outcomes) in people with type 2 diabetes.
METHODS
In this two-armed randomized clinical trial, people with type 2 diabetes were recruited within a primary care setting and randomized 1:1 to a smartphone-delivered dietary education for 12 weeks or a control group receiving regular care only. Dietary intake and cardiometabolic risk markers were measured at baseline and after 3 months. Diet was assessed using a 4-day dietary record and a food frequency questionnaire (FFQ). Overall diet quality was estimated with a Nordic Nutrition Recommendation (NNR) score and specific dietary intake was estimated for 13 food groups/nutrients. We used linear regression models to examine differences in change from baseline to the 3-month follow-up between the intervention and control group, adjusted for baseline values of each outcome variable.
RESULTS
The study included 129 participants (67 in the intervention group and 62 controls), of whom 61% were men. At baseline, mean age was 63.0 years and mean body mass index was 29.8 kg/m. When analyzing dietary record data, we found no effect of the intervention on diet quality or intake, however, the control group had increased their score by 1.6 points (95%CI: -2.9, -0.26) compared to the intervention group. In the analyses of FFQ data, the intervention group had lowered their daily intake in grams of saturated (β = -4.1, 95%CI: -7.9, -0.2) and unsaturated (mono- and polyunsaturated) (β = -6.9, 95%CI: -13.5, -0.4) fat more than the control group. The intervention group also presented lower serum triglycerides levels than the controls (β = -0.33, 95%CI: -0.60, -0.05). No statistical differences were found in any other dietary variables or cardiometabolic risk markers.
CONCLUSION
While we found no effect on overall diet quality, our findings suggest that a smartphone-based dietary education might impact dietary fat intake and corresponding cardiometabolic risk markers in people with type 2 diabetes. Our results should be considered hypothesis-generating and need to be confirmed in future studies.
TRIAL REGISTRATION
Registered at ClinicalTrials.gov ( NCT03784612 ). Registered 24 December 2018.
© 2025. The Author(s).
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.